Kolon Life Science Inc (102940) — Financial Flexibility Index
Kolon Life Science Inc (102940) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of ₩10.63 Billion (operating CF ₩2.58 Billion minus capex ₩8.05 Billion) represents 0% of total liabilities (₩295.72 Billion). Also explore 102940 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kolon Life Science Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Kolon Life Science Inc across 11 annual periods. Check Kolon Life Science Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kolon Life Science Inc (2014–2024)
Year-by-year free cash flow to debt coverage for Kolon Life Science Inc. For the full company profile including market capitalisation, see 102940 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | ₩-5.36 Billion | ₩-14.08 Billion | ₩270.23 Billion | ▲ +76.7% |
| 2023 | -0.09x | ₩-14.63 Billion | ₩-24.87 Billion | ₩171.76 Billion | ▲ +14.3% |
| 2022 | -0.10x | ₩-14.55 Billion | ₩-20.85 Billion | ₩146.39 Billion | ▼ -14.1% |
| 2021 | -0.09x | ₩-11.77 Billion | ₩-16.19 Billion | ₩135.25 Billion | ▼ -263.2% |
| 2020 | -0.02x | ₩-4.56 Billion | ₩-7.31 Billion | ₩190.38 Billion | ▼ -140.1% |
| 2019 | 0.06x | ₩10.60 Billion | ₩-20.18 Billion | ₩177.27 Billion | ▼ -64.2% |
| 2018 | 0.17x | ₩28.84 Billion | ₩-13.60 Billion | ₩172.76 Billion | ▲ +31.9% |
| 2017 | 0.13x | ₩21.68 Billion | ₩-8.29 Billion | ₩171.38 Billion | ▼ -72.9% |
| 2016 | 0.47x | ₩44.25 Billion | ₩28.11 Billion | ₩94.78 Billion | ▲ +20.7% |
| 2015 | 0.39x | ₩36.02 Billion | ₩20.81 Billion | ₩93.17 Billion | ▲ +3.7% |
| 2014 | 0.37x | ₩27.10 Billion | ₩12.10 Billion | ₩72.72 Billion | — |